Reducing YAP expression in Pkd1 mutant mice does not improve the cystic phenotype
Authors:
- Chiara FormicaCFChiara Formica
- Dorien J. M. PetersDPDorien J. M. Peters
- the DIPAK ConsortiumTCthe DIPAK Consortium
Open Access
- 27 June 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (15) , 8876-8882
Abstract
The Hippo pathway is a highly conserved signalling route involved in organ size regulation. The final effectors of this pathway are two transcriptional coactivators, yes‐associated protein (YAP) and transcriptional coactivator with PDZ‐binding motif (WWTR1 or TAZ). Previously, we showed aberrant activation of the Hippo pathway in autosomal‐dominant polycystic kidney disease (ADPKD), suggesting that YAP/TAZ might play a role in disease progression. Using antisense oligonucleotides (ASOs) in a mouse model for ADPKD, we efficiently down‐regulated Yap levels in the kidneys. However, we did not see any effect on cyst formation or growth. Moreover, the expression of YAP/TAZ downstream targets was not changed, while WNT and TGF‐β pathways' downstream targets Myc, Acta2 and Vim were more expressed after Yap knockdown. Overall, our data indicate that reducing YAP levels is not a viable strategy to modulate PKD progression.Keywords
Funding Information
- Nierstichting (LSHM15018, NSN P12.18, CP15.01, CP10.12)
- FP7 People: Marie-Curie Actions (317246)
This publication has 16 references indexed in Scilit:
- In vitro 3D phenotypic drug screen identifies celastrol as an effectivein vivoinhibitor of polycystic kidney diseaseJournal of Molecular Cell Biology, 2019
- Four‐jointed knock‐out delays renal failure in an ADPKD model with kidney injuryThe Journal of Pathology, 2019
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerCell, 2015
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growthNature Cell Biology, 2015
- Signal integration in TGF-β, WNT, and Hippo pathwaysF1000Prime Reports, 2013
- Altered Hippo signalling in polycystic kidney diseaseThe Journal of Pathology, 2011
- Lowering of Pkd1 expression is sufficient to cause polycystic kidney diseaseHuman Molecular Genetics, 2004
- Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathwayNature Cell Biology, 2003
- PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane ProteinScience, 1996
- The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16Cell, 1994